Opto Circuits (India) wholly-owned subsidiary, EuroCor in Germany, has received CE (Communité European) Mark approval for marketing its new polymer-free Paclitaxel-eluting coronary stent system called Taxcor-I.
This product, which is used in Coronary Angioplasty (Percutaneous Transluminal Coronary Angioplasty), is a second-generation innovation of EuroCors present blockbuster DES (drug-eluting stent) product - Taxcor.
Polymeric drug carriers, coated on the stents, have been known to cause blood clot formations, also leading to late thrombotic complications. EuroCor is the first manufacturer of a drug-eluting coronary stent system, which uses a new, polymer-free drug attachment technology. Taxcor-I considerably enhances patient safety and completely eliminates any polymer-related late adverse effects unlike many other drug eluted stent offerings from global giants.
|
|
|
|
|
| Posted : 7/11/2006 |
|
|
|
|
